Rocket Lab (RKLB) Gains on Bloomberg Report of Upcoming NASA Bulk Launch Orders

Key Takeaways

Table of Contents

Shares of Rocket Lab gained approximately 4% on Tuesday following a Bloomberg report indicating NASA is close to making bulk rocket launch purchases for its lunar base initiative.
The space agency may order four to five different rocket variants simultaneously, pairing each with commercial lunar landing vehicles.
This development follows SpaceX’s decision to halt new dedicated Falcon 9 reservations beyond 2028, creating opportunities for competitors such as Rocket Lab’s Neutron vehicle.
Over the past month, RKLB stock has climbed 14%, contrasting sharply with the Aerospace-Defense sector’s 5% downturn.
Second quarter fiscal 2026 revenue surged 62% annually to $234.1 million, driven by a 94% increase in Space Systems revenue.

Rocket Lab shares advanced on Tuesday, trading approximately 4% higher near the $75.70 mark. The upward movement followed Bloomberg’s disclosure that NASA is finalizing a bulk procurement strategy for rocket launches supporting its $30 billion lunar base initiative.

Rocket Lab USA, Inc., RKLB

According to Bloomberg, Carlos García-Galán, who manages NASA’s moon base program, indicated the agency will “probably announce the first set of these bulk buys” in the near future. The procurement strategy could encompass four or five different rocket configurations purchased in a single transaction.

Each launch vehicle would be designated to work alongside a commercial lunar lander. NASA indicated that any surplus launch capacity might be allocated to additional government agencies.

The announcement coincides with World Space Week, which launched October 4 in over 100 nations. This year’s theme, “Rocket Revolution,” highlights decreasing launch expenses as a catalyst for expanding space-related endeavors.

SpaceX Capacity Constraints Create Market Opening

A significant market shift is unfolding alongside the NASA procurement news. SpaceX has begun declining satellite operators seeking dedicated Falcon 9 missions scheduled after 2028.

This capacity limitation has created a market opportunity for emerging launch providers. Rocket Lab’s Neutron vehicle is among several contenders positioning themselves, joined by Relativity Space’s Terran R, Firefly Aerospace’s Eclipse, and Stoke Space’s Nova.

These vehicles have yet to demonstrate high-frequency operational capability. Establishing consistent launch schedules requires years of development, making it uncertain whether any will achieve regular flight operations by 2029.

Rocket Lab’s operations extend beyond Neutron development. The organization manufactures the Electron launch vehicle, Photon satellite platforms, and executes complete missions for both governmental and commercial clients.

Financial Performance Driving Stock Momentum

Tuesday’s gain extends RKLB’s recent positive trajectory. Over the last month, shares have appreciated 13.6%, while the Zacks Aerospace-Defense Equipment industry declined 5% during the identical timeframe.

Industry competitors have underperformed. Curtiss-Wright decreased 4.6% and TransDigm fell 6% over the comparable period.

The company’s expansion stems primarily from its Space Systems division. Rocket Lab produces solar cells, composite structures, star trackers, batteries, and additional spacecraft components.

During Q2 2026, overall revenue increased 62% year-over-year to $234.1 million. Space Systems revenue specifically surged 94% to $189.5 million, boosted by strategic acquisitions and expanded manufacturing operations.

Gross profit for the segment more than doubled, reaching $65.5 million. The quarter concluded with a $2.36 billion contract backlog.

In September, Rocket Lab unveiled IMM Apex, an advanced solar cell technology. The company reports 31.5% efficiency at beginning of life with 40% reduced mass compared to legacy germanium-based alternatives, engineered for direct integration into current spacecraft platforms.

According to Rocket Lab, over 1,100 satellites currently operate using its solar technologies. This established record supports the commercial case for IMM Apex.

Examining the balance sheet, Rocket Lab maintains a debt-to-capital ratio of 0.83%, significantly lower than the industry benchmark of 61.13%. Its current ratio stands at 5.48, substantially exceeding the industry’s 2.06.

Traditional valuation metrics indicate premium pricing. RKLB trades at 35.25 times forward 12-month sales, relative to the industry average of 7.04 times.

Zacks presently assigns Rocket Lab a #2 (Buy) rating, highlighting upward earnings estimate revisions coupled with the stock’s recent performance. The consensus 2026 EPS forecast has increased 50% during the previous 60 days.

✨ Limited Time Offer